Edition:
United States

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

10.45USD
20 Apr 2018
Change (% chg)

$0.15 (+1.46%)
Prev Close
$10.30
Open
$10.25
Day's High
$10.60
Day's Low
$10.20
Volume
11,565
Avg. Vol
34,849
52-wk High
$16.15
52-wk Low
$6.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -1.110
Sep '17 0.00 -1.095
Jun '17 0.00 -1.332
Mar '17 0.00 -1.344
FY 2016 Dec '16 0.00 -1.525
Sep '16 0.00 -1.492
Jun '16 0.00 -1.867
Mar '16 0.00 -10.418
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-19 6 2.08 12.47 0.00 12.47
Earnings (per share)
Quarter Ending Jun-18 6 -1.01 -0.61 -1.19 -1.64
Quarter Ending Sep-18 6 -1.00 -0.53 -1.26 -1.60
Year Ending Dec-18 6 -4.24 -2.32 -5.31 -5.06
Year Ending Dec-19 6 -3.80 -2.42 -5.10 -4.94
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 188.22 33.60
P/E High - Last 5 Yrs. -- 284.72 45.95
P/E Low - Last 5 Yrs. -- 95.76 24.93
Beta 1.58 0.75 0.80
Price to Sales (TTM) -- 136.15 7.07
Price to Book (MRQ) 4.88 19.54 5.13
Price to Tangible Book (MRQ) 4.88 24.07 6.73
Price to Cash Flow (TTM) -- 122.99 25.52
% Owned Institutions 77.11 11.18 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.94 3.93
Payout Ratio(TTM) -- 9.18 20.35

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 103.73 9.02
Sales (TTM) vs TTM 1 Yr. Ago -- 79.72 10.83
Sales - 5 Yr. Growth Rate -- 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 27.18 -66.87 22.25
EPS (TTM) vs TTM 1 Yr. Ago 68.10 -- --
EPS - 5 Yr. Growth Rate -- 47.46 10.26
Capital Spending - 5 Yr. Growth Rate -1.73 45.48 10.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.53
Current Ratio (MRQ) 5.85 5.97 3.62
LT Debt to Equity (MRQ) 58.13 23.32 11.31
Total Debt to Equity (MRQ) 67.01 25.75 13.97
Interest Coverage (TTM) -66.84 -186.61 30.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 36.56 54.01
Gross Margin - 5 Yr. Avg. -- 55.38 52.12
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -152.18 15.89
Operating Margin (TTM) -- -563.03 4.33
Operating Margin - 5 Yr. Avg. -- -164.18 11.25
Pre-Tax Margin (TTM) -- -535.84 4.97
Pre-Tax Margin - 5 Yr. Avg. -- -171.12 11.56
Net Profit Margin (TTM) -- -524.81 1.58
Net Profit Margin - 5 Yr. Avg. -- -171.01 7.89
Effective Tax Rate (TTM) -- -0.44 31.30
Effective Tax Rate - 5 Yr. Avg. -- 18.14 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,887,722 816,988,634
Net Income/Employee (TTM) -2,653,000 956,935 96,050,323
Receivable Turnover (TTM) -- 6.24 5.56
Inventory Turnover (TTM) -- 2.37 3.45
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -81.93 -0.77 10.54
Return on Assets - 5 Yr. Avg. -57.63 0.70 11.56
Return on Investment (TTM) -93.23 -0.74 13.19
Return on Investment - 5 Yr. Avg. -68.31 4.20 14.97
Return on Equity (TTM) -134.24 -2.80 15.00
Return on Equity - 5 Yr. Avg. -411.73 -0.05 16.25
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 37.96 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Eiger BioPharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.11%
# of Holders: 66
Total Shares Held: 8,117,131
3 Mo. Net Change: 34,793
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.